Sivik Global Healthcare LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 42.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,000 shares of the healthcare conglomerate’s stock after selling 7,500 shares during the period. UnitedHealth Group accounts for about 1.1% of Sivik Global Healthcare LLC’s portfolio, making the stock its 29th biggest position. Sivik Global Healthcare LLC’s holdings in UnitedHealth Group were worth $4,806,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. Bank Julius Baer & Co. Ltd Zurich increased its position in UnitedHealth Group by 97,436.9% during the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,029,274,230 shares of the healthcare conglomerate’s stock valued at $494,710,366,000 after acquiring an additional 1,028,218,963 shares during the last quarter. BlackRock Inc. raised its position in UnitedHealth Group by 0.7% in the 1st quarter. BlackRock Inc. now owns 74,928,539 shares of the healthcare conglomerate’s stock worth $35,410,478,000 after purchasing an additional 509,633 shares during the period. Wellington Management Group LLP boosted its position in shares of UnitedHealth Group by 0.6% during the first quarter. Wellington Management Group LLP now owns 24,079,140 shares of the healthcare conglomerate’s stock valued at $11,379,561,000 after buying an additional 140,312 shares during the period. Geode Capital Management LLC raised its holdings in shares of UnitedHealth Group by 1.4% in the first quarter. Geode Capital Management LLC now owns 17,101,395 shares of the healthcare conglomerate’s stock worth $8,063,262,000 after buying an additional 242,959 shares during the period. Finally, Morgan Stanley boosted its holdings in UnitedHealth Group by 13.8% during the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after acquiring an additional 1,893,192 shares during the period. Hedge funds and other institutional investors own 85.69% of the company’s stock.
UnitedHealth Group Stock Performance
Shares of UNH stock opened at $541.21 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.65. The company has a market cap of $500.58 billion, a PE ratio of 23.49, a PEG ratio of 1.64 and a beta of 0.63. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $553.00. The business’s fifty day simple moving average is $513.54 and its 200-day simple moving average is $496.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Friday, October 13th. The healthcare conglomerate reported $6.56 earnings per share for the quarter, topping the consensus estimate of $6.33 by $0.23. The business had revenue of $92.36 billion during the quarter, compared to the consensus estimate of $91.41 billion. UnitedHealth Group had a return on equity of 26.58% and a net margin of 6.02%. The company’s quarterly revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the company earned $5.79 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 24.94 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, December 4th will be given a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.39%. The ex-dividend date of this dividend is Friday, December 1st. UnitedHealth Group’s payout ratio is 32.64%.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on UNH shares. TD Cowen lowered their target price on shares of UnitedHealth Group from $562.00 to $555.00 and set an “outperform” rating for the company in a research note on Monday, July 17th. Jefferies Financial Group upped their target price on shares of UnitedHealth Group from $529.00 to $531.00 and gave the stock a “hold” rating in a research note on Monday, October 9th. UBS Group raised shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and lifted their price target for the company from $520.00 to $640.00 in a research note on Monday, October 16th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Thursday, September 14th. Finally, Stephens restated an “overweight” rating and set a $560.00 price target on shares of UnitedHealth Group in a research note on Friday, August 11th. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $578.30.
Check Out Our Latest Analysis on UNH
Insiders Place Their Bets
In other news, EVP Erin Mcsweeney sold 4,498 shares of the firm’s stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $544.28, for a total value of $2,448,171.44. Following the completion of the transaction, the executive vice president now directly owns 9,218 shares in the company, valued at $5,017,173.04. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 4,498 shares of the firm’s stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the completion of the transaction, the executive vice president now directly owns 9,218 shares of the company’s stock, valued at approximately $5,017,173.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Stephen J. Hemsley sold 121,515 shares of the company’s stock in a transaction on Tuesday, October 17th. The shares were sold at an average price of $540.58, for a total transaction of $65,688,578.70. Following the completion of the sale, the director now directly owns 521,818 shares in the company, valued at $282,084,374.44. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.